Relay Therapeutics
RLAY
RLAY
140 hedge funds and large institutions have $3.38B invested in Relay Therapeutics in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.73% more ownership
Funds ownership: 102.73% → 104.46% (+1.7%)
9% more call options, than puts
Call options by funds: $2.46M | Put options by funds: $2.26M
1% less capital invested
Capital invested by funds: $3.41B → $3.38B (-$22.2M)
Holders
140
Holding in Top 10
7
Calls
$2.46M
Puts
$2.26M
Top Buyers
| 1 | +$41.9M | |
| 2 | +$25.3M | |
| 3 | +$15.3M | |
| 4 |
NI
Nextech Invest
Zurich,
Switzerland
|
+$14.2M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$9.1M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$15.6M | |
| 3 | -$5.6M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$5.46M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.57M |